Mechanism of penicillin killing in the absence of bacterial lysis.

PubWeight™: 0.85‹?›

🔗 View Article (PMC 172737)

Published in Antimicrob Agents Chemother on October 01, 1989

Authors

T D McDowell1, K E Reed

Author Affiliations

1: Department of Microbiology, University of New Mexico School of Medicine, Albuquerque 87131.

Articles cited by this

Growth of several cariogenic strains of oral streptococci in a chemically defined medium. Infect Immun (1975) 9.48

Growth characteristics of group A streptococci in a new chemically defined medium. Infect Immun (1980) 5.90

The mechanism of the irreversible antimicrobial effects of penicillins: how the beta-lactam antibiotics kill and lyse bacteria. Annu Rev Microbiol (1979) 5.33

Tolerant response of Streptococcus sanguis to beta-lactams and other cell wall inhibitors. Antimicrob Agents Chemother (1977) 3.17

Balanced macromolecular biosynthesis in "protoplasts" of Streptococcus faecalis. J Bacteriol (1971) 2.77

Induction of bacterial lysis by penicillin. J Bacteriol (1957) 2.69

Evaluation of the bactericidal activity of beta-lactam antibiotics on slowly growing bacteria cultured in the chemostat. Antimicrob Agents Chemother (1986) 2.68

Studies on antibiotic synergism and antagonism; the interference of chloramphenicol with the action of penicillin. AMA Arch Intern Med (1951) 2.58

Early changes in the ultrastructure of Streptococcus faecalis after amino acid starvation. J Bacteriol (1970) 2.32

A rapid, guantitative, and selective estimation of radioactively labeled peptidoglycan in gram-positive bacteria. Anal Biochem (1971) 2.16

Effect of inhibition of deoxyribonucleic acid and protein synthesis on the direction of cell wall growth in Streptococcus faecalis. J Bacteriol (1974) 2.15

Lysis of nongrowing Escherichia coli by combinations of beta-lactam antibiotics and inhibitors of ribosome function. Antimicrob Agents Chemother (1986) 1.76

Penicillin tolerance in multiply drug-resistant natural isolates of Streptococcus pneumoniae. J Infect Dis (1985) 1.74

Inhibition of peptidoglycan, ribonucleic acid, and protein synthesis in tolerant strains of Streptococcus mutans. Antimicrob Agents Chemother (1980) 1.65

Cell envelope of Neisseria gonorrhoeae: penicillin enhancement of peptidoglycan hydrolysis. Infect Immun (1977) 1.42

Escherichia coli mutants tolerant to beta-lactam antibiotics. J Bacteriol (1979) 1.40

Penicillin-resistant and penicillin-tolerant mutants of group A Streptococci. Antimicrob Agents Chemother (1982) 1.36

Factors regulating cell wall thickening and intracellular iodophilic polysaccharide storage in Streptococcus mutans. Infect Immun (1977) 1.26

Conservation of cell wall peptidoglycan by strains of Streptococcus mutans and Streptococcus sanguis. Infect Immun (1980) 1.12

Unbalanced growth and macromolecular synthesis in Streptococcus mutans FA-1. Infect Immun (1976) 1.06

Decrease in ribosomal density of Proteus mirabilis exposed to subinhibitory concentrations of ampicillin or cephalothin. Proc Soc Exp Biol Med (1975) 0.95

Absence of autolytic activity (peptidoglycan nicking) in penicillin-induced nonlytic death in a group A streptococcus. J Bacteriol (1988) 0.94

Talk-back regulation: a regulatory response to the inhibitions of cell surface growth. Microbios (1989) 0.86

Articles by these authors

Identification of the gene encoding lipoate-protein ligase A of Escherichia coli. Molecular cloning and characterization of the lplA gene and gene product. J Biol Chem (1994) 1.73

Cloning of a Vibrio cholerae vibriobactin gene cluster: identification of genes required for early steps in siderophore biosynthesis. J Bacteriol (1997) 1.65

Lipoic acid metabolism in Escherichia coli: the lplA and lipB genes define redundant pathways for ligation of lipoyl groups to apoprotein. J Bacteriol (1995) 1.64

Lipoic acid metabolism in Escherichia coli: isolation of null mutants defective in lipoic acid biosynthesis, molecular cloning and characterization of the E. coli lip locus, and identification of the lipoylated protein of the glycine cleavage system. J Bacteriol (1991) 1.51

Increased protein secretion and adherence to HeLa cells by Shigella spp. following growth in the presence of bile salts. Infect Immun (1995) 1.50

Molecular cloning and expression of rat connexin40, a gap junction protein expressed in vascular smooth muscle. J Membr Biol (1992) 1.19

The incidence of salmonellosis among dairy herds in the northeastern United States. J Dairy Sci (2009) 1.14

Biotinylation of proteins in vivo: a useful posttranslational modification for protein analysis. Methods Enzymol (2000) 1.07

An active school model to promote physical activity in elementary schools: action schools! BC. Br J Sports Med (2008) 1.06

Molecular virology of hepatitis C virus: an update with respect to potential antiviral targets. Antivir Ther (1998) 1.05

The duration of fecal Salmonella shedding following clinical disease among dairy cattle in the northeastern USA. Prev Vet Med (2009) 0.93

Talk-back regulation: a regulatory response to the inhibitions of cell surface growth. Microbios (1989) 0.86

Disease management program improves asthma outcomes. Am J Manag Care (2000) 0.84

Exercise interventions for health: time to focus on dimensions, delivery, and dollars. Br J Sports Med (2003) 0.79

Cloning and assembly of complex libraries of full-length HCV cDNA clones. Methods Mol Med (1999) 0.79

An inpatient smoking control service. Hosp Manage (1967) 0.79

Use of the vaccinia virus/t7 expression system for studying HCV protein processing. Methods Mol Med (1999) 0.77

Effects of medium composition on penicillin-induced hydrolysis and loss of RNA and culture turbidity in group A streptococci. J Bacteriol (1989) 0.75

Fossil collecting. Science (1995) 0.75

Combining isotopic and ecomorphological data to refine bovid paleodietary reconstruction: a case study from the Makapansgat Limeworks hominin locality. J Hum Evol (1999) 0.75

Promoting clinical scholarship through scholarly writing. Nurse Educ (2005) 0.75

Maintaining ethical principles and surviving in a competitive environment. Bull Am Protestant Hosp Assoc (1983) 0.75